Dalton obtains notice of award form NIDA for research
The award is intended to support the discovery of a novel series of potent compounds targeting drug abuse and alleviate pain. Dalton Medicinal Chemistry co-founder Judd Berman said,
The European Medicines Agency (EMA) has validated the marketing authorisation application (MAA) from Pfizer and Valneva for their Lyme disease vaccine candidate, PF-07307405.
Cegedim’s Mobile Intelligence via the cloud empowers companies with a centralized platform to consolidate interactions, improve governance and enhance strategy execution. Aptalis Pharma International Specialty Pharmaceuticals president Jean-Louis